| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459172 | Radiotherapy and Oncology | 2018 | 8 Pages |
Abstract
Patients receiving pemetrexed after brain-directed stereotactic radiation appear to benefit from improved intracranial disease control at the possible expense of radiation-related radiographic necrosis. Whether symptomatic radiation injury occurs more frequently in patients receiving pemetrexed requires further study.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Daniel N. Cagney, Allison M. Martin, Paul J. Catalano, Zachary J. Reitman, Gabrielle A. Mezochow, Eudocia Q. Lee, Patrick Y. Wen, Stephanie E. Weiss, Paul D. Brown, Manmeet S. Ahluwalia, Nils D. Arvold, Shyam K. Tanguturi, Daphne A. Haas-Kogan,